Covered recipient · General Payments record
NAKIA HENRY
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2022–2024
$541.11
- Reported across 31 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $346.44 | 25 |
| Education | $87.49 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $228.53 | 18 |
| Teva Pharmaceuticals USA, Inc. | $103.11 | 2 |
| SK Life Science, Inc. | $36.27 | 2 |
| Neurocrine BioSciences, Inc. | $34.21 | 2 |
| Vanda Pharmaceuticals Inc. | $17.59 | 1 |
| UCB, Inc. | $14.22 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.78 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107321452 | CMS |
| ABBVIE INC. | $12.50 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107321454 | CMS |
| ABBVIE INC. | $7.19 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107321456 | CMS |
| ABBVIE INC. | $8.33 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107321458 | CMS |
| ABBVIE INC. | $17.69 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107321460 | CMS |
| ABBVIE INC. | $14.14 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107321462 | CMS |
| ABBVIE INC. | $16.93 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107321464 | CMS |
| ABBVIE INC. | $9.29 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107321466 | CMS |
| ABBVIE INC. | $8.45 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107321468 | CMS |
| ABBVIE INC. | $16.19 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107321470 | CMS |
| ABBVIE INC. | $13.62 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107321472 | CMS |
| ABBVIE INC. | $15.45 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107321474 | CMS |
| ABBVIE INC. | $16.58 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107321476 | CMS |
| ABBVIE INC. | $14.11 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107321478 | CMS |
| ABBVIE INC. | $16.08 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107321480 | CMS |
| ABBVIE INC. | $0.85 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107321482 | CMS |
| ABBVIE INC. | $18.15 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107321484 | CMS |
| ABBVIE INC. | $7.20 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107321486 | CMS |
| Neurocrine Biosciences, Inc. | $13.87 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151008073 | CMS |
| Neurocrine Biosciences, Inc. | $20.34 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150978138 | CMS |
| SK Life Science, Inc. | $18.73 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154139676 | CMS |
| SK Life Science, Inc. | $17.54 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154139688 | CMS |
| Teva Pharmaceuticals USA, Inc. | $15.62 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151572469 | CMS |
| Teva Pharmaceuticals USA, Inc. | $87.49 | 04/30/2024 | Education | Undisputed | 01/23/2026 | 1151572509 | CMS |
| UCB, Inc. | $14.22 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143500673 | CMS |
| Vanda Pharmaceuticals Inc. | $17.59 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133947326 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.